Here, GRHL2 suppressed EMT mediated by the TGF-β signaling pathway and it was downregulated in EMT-dependent mammary tumours (claudin low, metaplastic) and cell lines (basal-B). This evidence concerns the gene TGFB1 and breast cancer.